NATIXIS - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIXIS ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$16
-100.0%
1
-100.0%
0.00%
-100.0%
Q4 2021$13,536,000
+377.5%
579,961
+239.8%
0.05%
+360.0%
Q3 2021$2,835,000
+887.8%
170,661
+1350.6%
0.01%
+900.0%
Q2 2021$287,000
-96.8%
11,765
-93.1%
0.00%
-97.0%
Q4 2020$9,101,000
+2538.0%
170,240
+654.4%
0.03%
+1550.0%
Q2 2018$345,000
-8.2%
22,565
+80.7%
0.00%
-33.3%
Q4 2017$376,000
-70.3%
12,489
-62.8%
0.00%
-75.0%
Q3 2017$1,266,00033,6020.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders